68 related articles for article (PubMed ID: 14527683)
1. Drug-sensitivity pattern analysis for study of functional relationship between gene products.
Hiwasa T; Shimada H; Sakaida T; Kitagawa M; Kuroiwa N; Ochiai T; Takiguchi M
FEBS Lett; 2003 Sep; 552(2-3):177-83. PubMed ID: 14527683
[TBL] [Abstract][Full Text] [Related]
2. Acquisition of drug resistance by constitutive suppression of NF-kappaB in ras-transformed NIH3T3 mouse fibroblasts.
Sakaida T; Iwadate Y; Yamaji S; Uehara M; Noda A; Takiguchi M; Yamaura A; Hiwasa T
Int J Oncol; 2003 Oct; 23(4):1071-7. PubMed ID: 12963987
[TBL] [Abstract][Full Text] [Related]
3. Ras, protein kinase C zeta, and I kappa B kinases 1 and 2 are downstream effectors of CD44 during the activation of NF-kappa B by hyaluronic acid fragments in T-24 carcinoma cells.
Fitzgerald KA; Bowie AG; Skeffington BS; O'Neill LA
J Immunol; 2000 Feb; 164(4):2053-63. PubMed ID: 10657658
[TBL] [Abstract][Full Text] [Related]
4. Sensitization against anticancer drugs by transfection with UBE2I variant gene into ras-NIH3H3 mouse fibroblasts.
Shiratori T; Shimada H; Kagaya A; Kuboshima M; Nabeya Y; Machida T; Goto K; Takiguchi M; Ochiai T; Hiwasa T
Anticancer Res; 2007; 27(5A):3227-33. PubMed ID: 17970065
[TBL] [Abstract][Full Text] [Related]
5. Nuclear factor-kappaB/IkappaB signaling pathway may contribute to the mediation of paclitaxel-induced apoptosis in solid tumor cells.
Huang Y; Johnson KR; Norris JS; Fan W
Cancer Res; 2000 Aug; 60(16):4426-32. PubMed ID: 10969788
[TBL] [Abstract][Full Text] [Related]
6. Modulation of p53 activity by IkappaBalpha: evidence suggesting a common phylogeny between NF-kappaB and p53 transcription factors.
Dreyfus DH; Nagasawa M; Gelfand EW; Ghoda LY
BMC Immunol; 2005 Jun; 6():12. PubMed ID: 15969767
[TBL] [Abstract][Full Text] [Related]
7. Aurora-A promotes gefitinib resistance via a NF-κB signaling pathway in p53 knockdown lung cancer cells.
Wu CC; Yu CT; Chang GC; Lai JM; Hsu SL
Biochem Biophys Res Commun; 2011 Feb; 405(2):168-72. PubMed ID: 21216229
[TBL] [Abstract][Full Text] [Related]
8. Nuclear factor-kappaB is constitutively active in C-cell carcinoma and required for RET-induced transformation.
Ludwig L; Kessler H; Wagner M; Hoang-Vu C; Dralle H; Adler G; Böhm BO; Schmid RM
Cancer Res; 2001 Jun; 61(11):4526-35. PubMed ID: 11389085
[TBL] [Abstract][Full Text] [Related]
9. Constitutive activation of NF-kappaB in Ki-ras-transformed prostate epithelial cells.
Kim BY; Gaynor RB; Song K; Dritschilo A; Jung M
Oncogene; 2002 Jul; 21(29):4490-7. PubMed ID: 12085227
[TBL] [Abstract][Full Text] [Related]
10. Shared pathways of IkappaB kinase-induced SCF(betaTrCP)-mediated ubiquitination and degradation for the NF-kappaB precursor p105 and IkappaBalpha.
Heissmeyer V; Krappmann D; Hatada EN; Scheidereit C
Mol Cell Biol; 2001 Feb; 21(4):1024-35. PubMed ID: 11158290
[TBL] [Abstract][Full Text] [Related]
11. Breast cancer metastasis suppressor 1 inhibits gene expression by targeting nuclear factor-kappaB activity.
Cicek M; Fukuyama R; Welch DR; Sizemore N; Casey G
Cancer Res; 2005 May; 65(9):3586-95. PubMed ID: 15867352
[TBL] [Abstract][Full Text] [Related]
12. Decrease in chemosensitivity against anticancer drugs by an esophageal squamous cell carcinoma SEREX antigen, AISEC.
Hiwasa T; Shimada H; Kuboshima M; Shiratori T; Kagaya A; Nabeya Y; Sugano S; Ochiai T; Matsubara H; Takiguchi M
Int J Oncol; 2009 Mar; 34(3):641-8. PubMed ID: 19212668
[TBL] [Abstract][Full Text] [Related]
13. p53-deficient cells display increased sensitivity to anthracyclines after loss of the catalytic subunit of the DNA-dependent protein kinase.
Fedier A; Moawad A; Haller U; Fink D
Int J Oncol; 2003 Nov; 23(5):1431-7. PubMed ID: 14532987
[TBL] [Abstract][Full Text] [Related]
14. Transformation suppressor activity of C3G is independent of its CDC25-homology domain.
Guerrero C; Fernandez-Medarde A; Rojas JM; Font de Mora J; Esteban LM; Santos E
Oncogene; 1998 Feb; 16(5):613-24. PubMed ID: 9482107
[TBL] [Abstract][Full Text] [Related]
15. Resistance to apoptosis induced by alkylating agents in v-Ha-ras-transformed cells due to defect in p53 function.
Kuo ML; Chou YW; Chau YP; Huang TS
Mol Carcinog; 1997 Apr; 18(4):221-31. PubMed ID: 9142217
[TBL] [Abstract][Full Text] [Related]
16. Protein kinase CK2 promotes aberrant activation of nuclear factor-kappaB, transformed phenotype, and survival of breast cancer cells.
Romieu-Mourez R; Landesman-Bollag E; Seldin DC; Sonenshein GE
Cancer Res; 2002 Nov; 62(22):6770-8. PubMed ID: 12438279
[TBL] [Abstract][Full Text] [Related]
17. Loss of tumor suppressor p53 decreases PTEN expression and enhances signaling pathways leading to activation of activator protein 1 and nuclear factor kappaB induced by UV radiation.
Wang J; Ouyang W; Li J; Wei L; Ma Q; Zhang Z; Tong Q; He J; Huang C
Cancer Res; 2005 Aug; 65(15):6601-11. PubMed ID: 16061640
[TBL] [Abstract][Full Text] [Related]
18. An in vitro model to optimize dose scheduling of multimodal radioimmunotherapy and chemotherapy: effects of p53 expression.
Blumenthal RD; Leone E; Goldenberg DM; Rodriguez M; Modrak D
Int J Cancer; 2004 Jan; 108(2):293-300. PubMed ID: 14639618
[TBL] [Abstract][Full Text] [Related]
19. Regulation of transformed state by calpastatin via PKCepsilon in NIH3T3 mouse fibroblasts.
Hiwasa T; Nakata M; Nakata M; Ohno S; Maki M; Suzuki K; Takiguchi M
Biochem Biophys Res Commun; 2002 Jan; 290(1):510-7. PubMed ID: 11779201
[TBL] [Abstract][Full Text] [Related]
20. Relationship between constitutive nuclear factor-kappaB (NF-kappaB) and inhibitor kappaB-alpha (IkappaB-alpha) in an interferon-alpha-sensitive human Burkitt lymphoma cell line.
Rath PC
Biochim Biophys Acta; 2005 Sep; 1741(3):253-63. PubMed ID: 15979856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
